Structure-activity relationships of ustiloxin analogues

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Molecular Biology

Background:

• Ustiloxin D is a natural product with potential biological activities.
• Understanding the structure-activity relationship (SAR) of ustiloxin D is crucial for developing new therapeutic agents.
• Tubulin polymerization is a key target for cancer chemotherapy.

Purpose of the Study:

• To synthesize novel ustiloxin D analogues with modifications to the macrocyclic core, bridgehead ether stereochemistry, and enantiomeric form.
• To evaluate the synthesized analogues for their ability to inhibit tubulin polymerization.
• To identify key structural features responsible for the biological activity of ustiloxin D.

Main Methods:

• Synthesis of four novel ustiloxin D analogues.
• Biological evaluation of analogues using tubulin polymerization inhibition assays.
• Structure-activity relationship analysis based on synthetic modifications.

Main Results:

• Four novel ustiloxin D analogues were successfully synthesized.
• Biological evaluation revealed that only 2,2-dimethyl-ustiloxin D retained significant tubulin polymerization inhibitory activity.
• Modifications to the macrocyclic core and stereochemistry significantly impacted activity.

Conclusions:

• The size of the macrocyclic core and the stereochemistry at the bridgehead ether are critical for the tubulin polymerization inhibitory activity of ustiloxin D analogues.
• 2,2-dimethyl-ustiloxin D represents a promising lead compound for further investigation.
• Further SAR studies are warranted to optimize the efficacy of ustiloxin D derivatives.